FBRX · Insider trading · 13F holders · Congress trades
Forte Biosciences, Inc. (FBRX)
Who is buying and selling FBRX: company insiders on SEC Form 4, hedge funds and superinvestors on Form 13F, and members of Congress under the STOCK Act. Every figure links to the filing or page it comes from.
- 13F filers holding
- 9
- Insider buys, 90 days
- $0
- Insider sales, 90 days
- $0
- Congress trades, 12 months
- 0
FBRX at a glance
- No open-market insider purchases or sales of FBRX were filed in the last 90 days.
- 9 13F filers hold FBRX among their 50 largest positions, worth $134.5M combined. The biggest bets by portfolio weight are Squadron Capital Management LLC (1.6%), Mpm Bioimpact LLC (1.3%) and Affinity Asset Advisors, LLC (1.2%). In their latest 13Fs, 3 managers opened a new position and 3 added to one.
- No member of Congress has disclosed a trade in FBRX.
FBRX insider trading
No open-market insider purchases or sales of FBRX were filed in the last 90 days.
Who owns FBRX? Hedge funds and superinvestors
9 13F filers hold FBRX among their 50 largest positions, worth $134.5M combined. The biggest bets by portfolio weight are Squadron Capital Management LLC (1.6%), Mpm Bioimpact LLC (1.3%) and Affinity Asset Advisors, LLC (1.2%). In their latest 13Fs, 3 managers opened a new position and 3 added to one.
| Manager | % of portfolio | Value | Shares | Last quarter | 13F |
|---|---|---|---|---|---|
| Orbimed Advisors LLCHedge fund | 0.6% | $33.5M | 1,577,705 | +31.8% shares | Q2 2026 |
| Affinity Asset Advisors, LLCHedge fund | 1.2% | $24.3M | 1,145,391 | +13.2% shares | Q2 2026 |
| Mpm Bioimpact LLCHedge fund | 1.3% | $21.0M | 987,448 | -1.3% shares | Q2 2026 |
| TCG Crossover Management, LLCHedge fund | 0.5% | $19.6M | 920,000 | New | Q2 2026 |
| Integral Health Asset Management, LLCHedge fund | 0.6% | $14.3M | 675,000 | — | Q2 2026 |
| Boxer Capital Management, LLCHedge fund | 0.4% | $5.8M | 274,500 | — | Q2 2026 |
| Trails Edge Capital Partners, LPHedge fund | 0.9% | $5.8M | 273,181 | New | Q2 2026 |
| Sphera Funds Management Ltd.Hedge fund | 0.8% | $5.3M | 249,693 | +35.0% shares | Q2 2026 |
| Squadron Capital Management LLCHedge fund | 1.6% | $4.8M | 225,000 | New | Q2 2026 |
Each manager counts with its latest 13F (Q2 2026: 9). Screen FBRX in the grand portfolio →
FBRX stock trades by members of Congress
No member of Congress has disclosed a trade in FBRX.
Analysis mentioning FBRX
Posts from the blog that cover Forte Biosciences, Inc., newest first.
FBRX questions and answers
Are insiders buying FBRX stock?
No open-market insider purchases or sales of FBRX were filed in the last 90 days.
Which hedge funds own FBRX?
9 13F filers hold FBRX among their 50 largest positions, worth $134.5M combined. The biggest bets by portfolio weight are Squadron Capital Management LLC (1.6%), Mpm Bioimpact LLC (1.3%) and Affinity Asset Advisors, LLC (1.2%). In their latest 13Fs, 3 managers opened a new position and 3 added to one.
Has Congress traded FBRX?
No member of Congress has disclosed a trade in FBRX.
Who is the largest holder of FBRX?
Among 13F filers, Orbimed Advisors LLC reports the largest FBRX position, $33.5M (1,577,705 shares) in its Q2 2026 13F. The biggest bet by portfolio weight is Squadron Capital Management LLC's: 1.6% of its portfolio.
Cite or share this
Free to use with a link back. The data updates every filing day.